Long-Term Liabilities: The sum of all non-current liabilities.
FibroBiologics Inc. (FBLG) had Long-Term Liabilities of $1.70M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-3.24M |
|
-- |
|
-- |
|
$2.59M |
|
$-2.59M |
|
$-0.65M |
|
$-3.24M |
|
$-3.24M |
|
$-3.24M |
|
$-3.24M |
|
$-3.24M |
|
$-3.24M |
|
$-2.59M |
|
$-2.36M |
|
2.23M |
|
2.23M |
|
$-0.60 |
|
$-0.60 |
|
| Balance Sheet Financials | |
$6.35M |
|
$0.84M |
|
$3.27M |
|
$9.62M |
|
$1.76M |
|
-- |
|
|
Long-Term Liabilities |
$1.70M |
$3.46M |
|
$6.16M |
|
$6.16M |
|
$6.16M |
|
3.33M |
|
| Cash Flow Statement Financials | |
$-16.39M |
|
$-0.26M |
|
$7.57M |
|
$13.98M |
|
$4.89M |
|
$-9.09M |
|
$2.69M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.61 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-16.66M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-52.70% |
|
-52.70% |
|
-33.72% |
|
-52.70% |
|
$1.85 |
|
$-7.46 |
|
$-7.34 |
|